Age‐specific prevalence of complement‐fixing antibodies to sixteen viral antigens: A computer analysis of 58,500 patients covering a period of eight years

The age‐specific prevalence of CF antibodies against 16 viral antigens was determined by using the computerized data registry of the routine diagnostic laboratory of the authors' department. The material consisted of data based on serum specimens from about 58,500 patients. All ages from newborn infants to 90‐year‐olds were represented. The sera had been collected and tested with a CF screening test over a period of 8 years (1971–1978). Several different antibody prevalence patterns were distinguished in regard to the rapidity and timing of the initial increase of the prevalence, as well as to the mode of later changes in prevalence. For most respiratory viruses a rapid increase of the prevalence was seen through the childhood continuing, for some of them, up to the 30s (influenza A and coronavirus), while rather variable patterns were found in the older age groups. Herpes simplex and cytomegaloviruses showed, interestingly, another type of pattern: a slow increase of prevalence continuing through the whole age range. The frequency of herpes simplex antibodies reached 90% by the age of 80 years. Antibody levels against any antigen in infants less than one‐month‐old were equal to those in 20‐ to 40‐year‐old adults, and the expected rapid decrease of antibodies took place within the first 6 months of life. Possible influences of epidemics and repeated exposures to different viruses (external boosting), and of latent or chronic infections (internal boosting), as wells as of technical variations, on the observed prevalence patterns are discussed.

[1]  A. Pönkä,et al.  Age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae during an 8-year period , 1983, Journal of clinical microbiology.

[2]  T. Hovi,et al.  Coronavirus infections of man associated with diseases other than the common cold , 2005, Journal of medical virology.

[3]  A. M. Collier,et al.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. , 1979, The New England journal of medicine.

[4]  R. Pyhälä,et al.  Influenza A(H1N1) viruses of the 1977/78 outbreak: isolation and haemagglutination properties , 1979, Journal of Hygiene.

[5]  C. von Bonsdorff,et al.  Rotavirus infections in adults in association with acute gastroenteritis , 1978, Journal of medical virology.

[6]  S. Pyrhönen,et al.  Lack of measurable complement fixing antibodies against viral antigens. , 2009, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology.

[7]  T. Hovi,et al.  Antibodies to human coronavirus OC43 measured by radial haemolysis in gel. , 1977, Scandinavian journal of infectious diseases.

[8]  P. Echeverria,et al.  Serological studies with reovirus-like enteritis agent , 1976, Infection and immunity.

[9]  J. Fox,et al.  The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. , 1975, American journal of epidemiology.

[10]  S. Inhorn,et al.  Serologic profile of children in a Mexican highland community: prevalence of complement-fixing antibodies to Mycoplasma pneumoniae, respiratory syncytial virus and parainfluenza viruses. , 1975, American journal of epidemiology.

[11]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics. , 1973, American journal of epidemiology.

[12]  P. Gardner Respiratory syncytial virus infections , 1973, Postgraduate medical journal.

[13]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. , 1973, American journal of epidemiology.

[14]  R. Jennings Adenovirus, parainfluenza virus and respiratory syncytial virus antibodies in the sera of Jamaicans , 1972, Journal of Hygiene.

[15]  P. Leinikki,et al.  Incidence of cytomegalovirus infections in early childhood. , 1972, Scandinavian journal of infectious diseases.

[16]  E. Alexander,et al.  Seroepidemiology of infectious due to members of the herpesvirus group. , 1971, American journal of epidemiology.

[17]  A. Tomlinson,et al.  The incidence of complement-fixing antibody to varicella-zoster virus in hospital patients and blood donors , 1970, Journal of Hygiene.

[18]  K. Cantell,et al.  [Mumps vaccination in the Finnish Defence Forces]. , 1969, Nordisk medicin.

[19]  K. Cantell,et al.  Mumps vaccination in the Finnish defense forces. , 1968, American journal of epidemiology.

[20]  I. Smith,et al.  The incidence of Herpesvirus hominis antibody in the population , 1967, Journal of Hygiene.

[21]  K. Cantell,et al.  Parainfluenza 1 (Sendai) antibodies and mumps vaccination. , 1967, Annales medicinae experimentalis et biologiae Fenniae.

[22]  J. B. Hanshaw Cytomegalovirus complement-fixing antibody in microcephaly. , 1966, The New England journal of medicine.

[23]  S. D. Elek,et al.  The incidence of infection with cytomegalovirus in a normal population: A serological study in Greater London , 1965, Journal of Hygiene.

[24]  A. Hornsleth,et al.  THE INCIDENCE OF COMPLEMENT-FIXING ANTIBODIES TO THE RESPIRATORY SYNCYTIAL VIRUS IN SERA FROM DANISH POPULATION GROUPS AGED 0-19 YEARS. , 1964, Acta pathologica et microbiologica Scandinavica.

[25]  M. H. Hambling A Survey of Antibodies to Respiratory Syncytial Virus in the Population* , 1964, British medical journal.

[26]  E. H. Lennette,et al.  Serologic responses to para-influenza viruses in patients with mumps virus injection. , 1963, The Journal of laboratory and clinical medicine.

[27]  B. Peeler,et al.  Immunization against parainfluenza infections. Antigenicity of egg a dapted types 1 and 3. , 1962, Journal of immunology.

[28]  R. Chanock,et al.  III. Myxoviruses: Parainfluenza , 1962 .

[29]  V. Bech Titers of complement fixing measles antibodies in human sera collected from one to five years after illness. , 2009, Acta pathologica et microbiologica Scandinavica.

[30]  D. Walker,et al.  Demonstration of antigenic relationship between mumps virus and hemagglutinating virus of Japan. , 1957, Journal of immunology.

[31]  A. Holzel,et al.  Herpes Simplex A Study of Complement‐Fixing Antibodies at Different Ages , 1953, Acta paediatrica.